Syracuse Biolabs, Inc. (SBL) is a Syracuse, NY based biotech firm which "accelerates bioinnovation through collaboration. Syracuse Biolabs is a for-profit S corporation focused on meeting its corporate mission by partnering with academic and start-up laboratories and leveraging federal funding mechanisms to drive novel biotechnologies from early stage funding through commercialization. Syracuse Biolabs founder, Dr. Mark McPike, has 15+ years preparing SBIR-STTR applications and leading funded Phase I and II SBIR-STTR projects as Principal Investigator (PI) and Co-PI. Dr. McPike has led projects from NIH, AFRL, HSARPA, and DOD.
| Website | http://www.syracusebiolabs.com |
| Employees | 1 (1 on RocketReach) |
| Address | 841 E Fayette St, Syracuse, New York 13210, US |
| Phone | +1 315-427-3441 |
| Industry | Software General, Software |
| Competitors | Amgen, Genentech, Regeneron, Biogen, Gilead Sciences, Novartis, Pfizer, Bristol Myers Squibb, Lilly India, Receptos, a wholly-owned subsidiary of Celgene +39 more (view full list) |
| SIC | SIC Code 73 Companies, SIC Code 738 Companies |
| NAICS | NAICS Code 561 Companies, NAICS Code 56 Companies |
Looking for a particular Syracuse Biolabs employee's phone or email?
Mark McPike is the President of Syracuse Biolabs.
1 people are employed at Syracuse Biolabs.
Syracuse Biolabs is based in Syracuse, New York.
The NAICS codes for Syracuse Biolabs are [561, 56].
The SIC codes for Syracuse Biolabs are [73, 738].